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ABSTRACT
Measures of muscle mass, strength, and function predict risk of incident fractures, but it is not known whether this risk information is
additive to that from FRAX (fracture risk assessment tool) probability. In the Osteoporotic Fractures in Men (MrOS) Study cohorts
(Sweden, Hong Kong, United States), we investigated whether measures of physical performance/appendicular lean mass (ALM) by
DXA predicted incident fractures in older men, independently of FRAX probability. Baseline information included falls history, clinical
risk factors for falls and fractures, femoral neck aBMD, and calculatedFRAXprobabilities. Anextensionof Poisson regressionwasused to
investigate the relationshipbetween time for ﬁve chair stands,walking speedover a 6mdistance, grip strength, ALMadjusted for body
size (ALM/height2), FRAX probability (major osteoporotic fracture [MOF]) with or without femoral neck aBMD, available in a subset of
n¼ 7531), and incident MOF (hip, clinical vertebral, wrist, or proximal humerus). Associations were adjusted for age and time since
baseline, and are reported as hazard ratios (HRs) for ﬁrst incident fracture per SD increment in predictor usingmeta-analysis. 5660men
in the United States (mean age 73.5 years), 2764 men in Sweden (75.4 years), and 1987 men in Hong Kong (72.4 years) were studied.
Mean follow-up time was 8.7 to 10.9 years. Greater time for ﬁve chair stands was associated with greater risk of MOF (HR 1.26; 95% CI,
1.19 to 1.34), whereas greater walking speed (HR 0.85; 95% CI, 0.79 to 0.90), grip strength (HR 0.77; 95% CI, 0.72 to 0.82), and ALM/
height2 (HR 0.85; 95% CI, 0.80 to 0.90) were associated with lower risk of incident MOF. Associations remained largely similar after
adjustment for FRAX, but associations between ALM/height2 and MOF were weakened (HR 0.92; 95% CI, 0.85 to 0.99). Inclusion of
femoral neck aBMDmarkedly attenuated the association between ALM/height2 and MOF (HR 1.02; 95% CI, 0.96 to 1.10). Measures of
physical performance predicted incident fractures independently of FRAX probability. Whilst the predictive value of ALM/height2was
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substantially reduced by inclusion of aBMD requires further study, these ﬁndings support the consideration of physical performance
in fracture risk assessment. © 2018 The Authors. Journal of Bone and Mineral Research Published by Wiley Periodicals Inc.
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Introduction
The place of falls as a major risk factor for fracture is wellestablished; themajority of hip fractures occur as a result of a
fall from standing height or less.(1,2) There is also substantial
evidence that risk factors related speciﬁcally to falls risk, such as
physical performance, function, and muscle indices, are also
related to the risk of incident fracture.(3–5) Current clinical
approaches to risk assessment are increasingly based on clinical
risk factors, with or without aBMD, through fracture risk
calculators. FRAX (fracture risk assessment tool) is the most
commonly used fracture risk assessment tool worldwide,(6) but
unlike other tools such as QFracture or the GARVAN
calculator,(7–9) it does not include falls as a speciﬁc input
risk factor(2,10) because of the inconsistent data across the 12
derivation and 11 validation cohorts.(11) We have previously
demonstrated that prior falls predict the risk of incident falls(12)
and fractures(13) independently of FRAX probability. Although
the predictive value of falls-related risk factors for incident
fracture have been demonstrated individually,(4,5) it has not
been established whether the risk information so provided will
be independent of that obtained through FRAX and aBMD.
This is an important consideration because if these measures
were to provide no additional information beyond the current
fracture risk assessment, then there would be little to be
gained from their measurement as part of fracture-risk
stratiﬁcation. Furthermore, it is not clear whether speciﬁc falls
risk factors, such as physical performance, might give
information independent of the reporting of prior falls
themselves. We therefore undertook a meta-analysis of the
three Osteoporotic Fractures in Men (MrOS) cohorts (United
States, Sweden, Hong Kong) to investigate whether the
predictive value of four measures (time for ﬁve chair stands,
walking speed over a distance of 6m, grip strength, and
appendicular lean mass [ALM]) for incident fracture was
independent of FRAX probability, history of falls, or aBMD.
Subjects and Methods
Participants
Details of the MrOS cohort studies have been published
previously.(12–15) Brieﬂy, MrOS is a multicenter study of
community-dwelling men aged 65 years or older from three
countries, recruited and evaluated using similar criteria. To be
eligible for the study, subjects had to be able towalkwithout aid.
In the MrOS Hong Kong study, 2000 Chinese men, aged 65 to 92
years, were enrolled between August 2001 and February
2003.(16) All were Hong Kong residents of Asian ethnicity.
Stratiﬁed sampling was adopted to ensure that 33% of subjects
were included in each of the following age groups: 65 to 69, 70
to 74, and 75 years. Recruitment notices were placed in
housing estates and community centers for the elderly. In
the MrOS Sweden study, 3014 men, aged 69 to 81 years, were
enrolled between October 2001 and December 2004.(12,17) The
cohort comprised men from the cities of Malm€o, Gothenburg,
and Uppsala, identiﬁed and recruited using national population
registers. More than 99% were of Caucasian ethnicity. The
participation rate in the MrOs Sweden study was 45%. In
the MrOS United States study, 5994 men, aged 65 to 100 years,
were enrolled at six sites between March 2000 and April
2002.(18,19) Each US clinical site designed and customized
strategies to enhance recruitment of its population. Common
strategies included mailings from the Department of Motor
Vehicles, voter registration and participant databases, common
seniors’ newspaper features and advertisements, and targeted
presentations. Self-deﬁned racial/ethnic ancestry was ascer-
tained through questionnaires at baseline.
Exposure variables
At baseline, height (cm) and weight (kg) were measured, and BMI
was calculated as kg/m2. The international MrOS questionnaire(18)
was administered at baseline to collect information about current
smoking habits, number and type of medications, fracture history,
family history of hip fracture, past medical history (rheumatoid
arthritis), andhighconsumptionof alcohol (threeormoreglassesof
alcohol-containing drinks per day), calculated from the reported
frequency and amount of alcohol use. Previous fracture at baseline
wasdocumentedas all fractures after the ageof 50 years regardless
of trauma. Glucocorticoid exposure was documented in MrOS as
use at least 3 times per week in the month preceding the baseline
assessment.Apart fromglucocorticoiduseand rheumatoidarthritis
(bothFRAX inputvariables), therewasno informationonsecondary
causes of osteoporosis and the “Secondary Osteoporosis” input
variable for FRAXprobability calculationwas set to “No” for allmen.
Self-reported falls during the 12 months preceding the baseline
were recorded by questionnaire (past falls). Time for ﬁve chair
stands, walking speed over 6m (at usual pace), and grip strength
using JAMAR dynamometers (Sammons Preston Rolyan, Boling-
brook, IL, USA) were assessed at the baseline visit. Areal bone
mineral density (aBMD)wasmeasuredat the femoralneckandALM
from whole body scans using Hologic QDR 4500 A or W (Hologic,
Bedford, MA, USA) or Lunar Prodigy (GE Lunar Corp., Madison, WI,
USA) depending on the center, with cross calibration of instru-
ments for aBMD. A T-score was calculated using NHANES (National
Health and Nutrition Examination Survey) young women as a
reference value.(20,21) A 10-year probability of fracture (FRAXmajor
osteoporotic fracture: hip, humerus, vertebral, or forearm sites) was
calculated using the clinical risk factors described above, with and
without femoral neck aBMD entered into country-speciﬁc FRAX
models.
Fracture and death outcomes
Hong Kong:(22) Incident fractures were captured via subject
follow-up through a phone call or a visit to the research center.
All fracture sites (hip, wrist, skull/face, ribs, shoulder, arm, wrist,
vertebra, tibia, ﬁbula, foot, metatarsal toes, hand, ﬁngers, and
pelvis) were recorded. Pathological fractures were excluded. All
incident fractures reported by participants were then conﬁrmed
by X-rays or medical records. Deaths were veriﬁed by death
certiﬁcates.
Sweden:(23) Central registers covering all Swedish citizens
were used to identify the subjects and the time of death for all
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subjects who died during the study; these analyses were
performed after the time of fracture validation. At the time of
fracture evaluation, the computerized X-ray archives in Malm€o,
Gothenburg, and Uppsala were searched for new fractures
occurring after the baseline visit using the unique personal
registration number allocated to every Swedish citizen. All
additional fractures reported by the study subject after the
baseline visit were conﬁrmed by physician review of radiology
reports. Fractures reported by the study subject, but not
conﬁrmed by radiographic report, were not included.
United States:(18) If a participant reported a fracture, study
staff conducted a follow-up telephone interview to determine
the date and time the fracture had occurred, a description of
how the fracture occurred, the type of trauma that resulted in
the fracture, the participant’s location and activities at the time
of the fracture, symptoms just before or coincident with the
fracture, and source of medical care for the fracture. All reported
fractures were centrally veriﬁed by a physician adjudicator
through medical records obtained from the participant’s
physician. Deaths were veriﬁed through state death certiﬁcates.
Statistical methods
Clinical outcomes comprised any fracture, osteoporotic fracture
(deﬁned according to Kanis et al., 2001(24) as clinical vertebral,
ribs, pelvis, humerus, clavicle, scapula, sternum, hip, other
femoral fractures, tibia, ﬁbula, distal forearm/wrist), major
osteoporotic fracture (MOF: hip, clinical vertebral, humerus, or
wrist/ forearm), and hip fracture. An extension of Poisson
regressionmodels(25)was used to study the association between
predictors, FRAX, prior falls, aBMD, and the future risk of fracture.
All associations were adjusted for age and time since baseline. In
contrast to logistic regression, the Poisson regression uses the
length of each individual’s follow-up period and the hazard
function is assumed to be exp(b0þb1 – current time from
baselineþb2 – current ageþb3 – variable of interest). The
observation period of each participant was divided into intervals
of one month. One fracture per person and time to the ﬁrst
fracture were counted; events were censored if they occurred
after the time of ﬁrst fracture, loss to follow-up, death, or end of
follow-up. To correct for body size, ALM for each individual was
divided by the square of their height. We initially investigated
the predictive value of each of the four exposures (chair stand
time, walking speed, grip strength, and ALM/height2, all
standardized to be normally distributed with mean¼ 0 and
SD¼ 1) adjusted only for age and follow-up time. Subsequently,
we used multivariate models to investigate the predictive value
of these indices independent of FRAX, prior falls, or aBMD
(entered into the model as femoral neck T-score). Additionally,
we investigated whether inclusion of BMI or levels of physical
activity (Physical Activity Scale for the Elderly [PASE] question-
naire(26)) modiﬁed the associations, and also explored the
predictive value of ALM/BMI. In further analyses, we investigated
interactions with age and time since baseline, in which age and
time were used as continuous variables and examples given at
speciﬁc ages and times. The association between predictive
factors and risk of fracture are described as a hazard ratio (HR)
per 1 SD change in predictor together with 95% conﬁdence
intervals (CIs). Two-sided p-values were used for all analyses; p<
0.05 was considered to be signiﬁcant. Analyses were undertaken
separately within each cohort; then the b-coefﬁcients from each
cohort were weighted according to the variance and merged to
determine the weighted mean of the coefﬁcient and its SD
(ﬁxed-effects meta-analysis because heterogeneity was low to
moderate as assessed by I2).(27) The risk ratios are then given by
e(weighted mean coefﬁcient).
Results
Characteristics of participants
The study cohort consisted of 10,411 men who had information
on the key exposures, together with prior falls and femoral neck
aBMD: 5660 men in the United States (mean age 73.5 years;
mean follow-up 10.9 years), 2764men in Sweden (mean age 75.4
years; mean follow-up 8.7 years), and 1987 men in Hong Kong
(mean age 72.4 years; mean follow-up 9.9 years). The frequency
of past falls was similar across the cohorts at 20%, 16%, and 15%,
respectively. Previous fractures were more commonly reported
in Sweden (35%) than in the United States (22%) and Hong Kong
(14%). Consistent with the known country-speciﬁc epidemiol-
ogy of fracture, the highest mean FRAX probability (major
osteoporotic fracture [MOF] with aBMD) was observed in
Sweden (11.4%), followed by the United States (7.8%) and
Hong Kong (6.6%). There were 61 men (0.6%) who were unable
to complete the chair stand test. Summary statistics for the key
exposure variables are presented in Table 1, which summarizes
the baseline characteristics of the individuals by country cohort.
Associations between chair stand time, walking speed,
grip strength, appendicular lean mass, and incident
fracture risk
Table 2 summarizes the associations between each of the four
predictors (chair stand time, walking speed, grip strength, and
ALM divided by height2, adjusted only for age and follow-up
time), and the fracture outcomes. Thus, across all cohorts,
greater time for ﬁve chair stands was associated with a greater
risk of MOF (HR 1.26; 95% CI, 1.19 to 1.34), whereas greater
walking speed (HR 0.85; 95% CI, 0.79 to 0.90), grip strength (HR
0.77; 95% CI, 0.72 to 0.82) and ALM/height2 (HR 0.85; 95%CI, 0.80
to 0.90) were associated with a lower risk of incident MOF.
Results for any fracture, osteoporotic fracture, and hip fracture
outcomes were very similar, as were associations by cohort.
Independent predictive value of exposures after
adjustment for prior falls or FRAX probability
The results of models additionally including prior fall or FRAX
(MOF with or without aBMD) are documented in Table 3. The
associations between each of the four exposures and any of the
fracture outcomes remained very similar with adjustment for
prior falls. The inclusion of FRAX [MOF without aBMD (using the
subset of 7531 for whom FRAX probability could be calculated)]
very slightly attenuated the magnitude of the HRs; in contrast,
although inclusion of FRAX (MOF with aBMD) led to a modest
attenuation of HRs in general, those for any fracture (HR 0.95;
95% CI, 0.90 to 1.01) and osteoporotic fracture (HR 0.95; 95% CI,
0.89 to 1.01) with ALM/height2 became nonsigniﬁcant, and that
between ALM/height2 and MOF was also attenuated (HR 0.92;
95% CI, 0.85 to 0.99). Adjustment for BMI or physical activity also
did not materially alter the magnitude of the relationships and
associations for ALM were similar to those for ALM/height2.
However, with ALM/BMI as the exposure, the patterns were
again of similar direction, but were attenuated such that none of
the models achieved statistical signiﬁcance (summarized in
Supplementary Table 1).
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Table 1. Baseline Characteristics and Fracture Outcomes of Study Participants by Country
Hong Kong Sweden USA
Proportion of whole cohort 99% 92% 94%
n 1987 2764 5660
Person-years 19,592 24,102 61,456
Age [mean (range)], years 72.4 (65–92) 75.4 (70–81) 73.5 (64–100)
BMI 23.5 3.1 26.3 3.5 27.4 3.8
Previous fracture 14% 35% 22%
Family history hip fracture 5% 13% 17%
Smoker 12% 8% 3%
Glucocorticoids 1% 2% 2%
Rheumatoid arthritis 1% 1% 5%
Excess alcohol 1% 2% 4%
aBMD FN T-score 1.4 0.9 0.9 1.0 0.6 1.1
Time 5 stands (s) 12.7 3.9 13.4 4.2 11.1 3.3
Walk speed (m/s) 1.0 0.2 1.3 0.3 1.2 0.2
Fall 15% 16% 20%
Grip strength (kg) 33.9 6.7 43.1 7.8 41.8 8.4
ALM (kg) 20.2 2.8 24.3 3.2 24.3 3.5
Height (cm) 163 5.7 175 6.5 174 6.8
ALM/height2 7.6 0.9 7.9 0.8 8.0 0.9
FRAX MOF without aBMD 6.9 2.9 13.5  6.1 9.1 4.8
FRAX hip without aBMD 3.4 2.5 7.5 5.5 3.6 3.9
FRAX MOF with aBMD 6.6 3.2 11.4 6.7 7.8 4.5
FRAX hip with aBMD 3.0 2.6
(n¼ 1661)
5.5 6.0
(n¼ 1732)
2.4 3.4
(n¼ 4138)
FU (hip fx: mean (SD), years 9.9 (2.8) 8.7 (2.9) 10.9 (3.8)
Any fx 11% 22% 19%
Osteoporotic fx 9% 19% 15%
MOF fx 7% 16% 10%
OWH fx (MOF) 4% 12% 5%
Hip fx 3% 7% 4%
FN¼ femoral neck; ALM¼ appendicular lean mass; FU¼ follow-up; FRAX¼ fracture risk assessment tool; fx¼ fracture; MOF¼major osteoporotic
fracture; OWH¼ osteoporotic fracture without hip fracture.
Table 2. Associations Between Exposures and Risk of Incident Fracture
Any fx Ost fx MOF fx Hip fx
Time 5 chair stands HK 1.13 (0.99, 1.30) 1.19 (1.02, 1.38) 1.24 (1.04, 1.46) 1.20 (0.93, 1.55)
SW 1.14 (1.06, 1.24) 1.21 (1.11, 1.31) 1.21 (1.10, 1.33) 1.38 (1.19, 1.60)
US 1.17 (1.10, 1.24) 1.18 (1.10, 1.26) 1.30 (1.20, 1.42) 1.38 (1.21, 1.58)
Total 1.15 (1.10, 1.21) 1.19 (1.13, 1.25) 1.26 (1.19, 1.34) 1.36 (1.24, 1.49)
Walking speed HK 0.84 (0.73, 0.97) 0.80 (0.68, 0.94) 0.78 (0.65, 0.93) 0.57 (0.44, 0.75)
SW 0.86 (0.79, 0.93) 0.84 (0.77, 0.91) 0.84 (0.76, 0.92) 0.72 (0.62, 0.84)
US 0.95 (0.89, 1.02) 0.93 (0.86, 1.00) 0.87 (0.79, 0.95) 0.73 (0.63, 0.84)
Total 0.91 (0.86, 0.95) 0.88 (0.83, 0.93) 0.85 (0.79, 0.90) 0.70 (0.64, 0.77)
Grip strength HK 0.76 (0.66, 0.88) 0.77 (0.66, 0.91) 0.75 (0.63, 0.90) 0.71 (0.54, 0.93)
SW 0.79 (0.73, 0.86) 0.78 (0.71, 0.85) 0.76 (0.69, 0.84) 0.69 (0.59, 0.80)
US 0.86 (0.81, 0.92) 0.80 (0.74, 0.86) 0.78 (0.71, 0.86) 0.74 (0.64, 0.86)
Total 0.83 (0.79, 0.86) 0.79 (0.75, 0.83) 0.77 (0.72, 0.82) 0.72 (0.65, 0.79)
ALM/Height2 HK 0.88 (0.76, 1.01) 0.84 (0.72, 0.99) 0.82 (0.69, 0.98) 0.74 (0.56, 0.97)
SW 0.85 (0.78, 0.92) 0.84 (0.76, 0.91) 0.82 (0.75, 0.91) 0.84 (0.72, 0.98)
US 0.91 (0.85, 0.96) 0.92 (0.85, 0.99) 0.89 (0.81, 0.97) 0.91 (0.79, 1.04)
Total 0.89 (0.84, 0.93) 0.88 (0.83, 0.93) 0.85 (0.80, 0.90) 0.86 (0.78, 0.95)
Data are hazard ratios (HRs) for fracture (fx) per 1 SD increase in predictor (HR/SD), adjusted for age and follow-up time. Statistically signiﬁcant
associations (p< 0.05) are in bold.
HK¼Hong Kong; SW¼ Sweden; US¼United States; fx¼ fracture; Ost¼ osteoporotic; MOF¼major osteoporotic fracture.
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Independent predictive value of exposures after
adjustment for femoral neck aBMD
Inclusion of femoral neck aBMD T-score (Table 3) had a very
modest attenuating effect on predictive value of chair stand
time, walking speed, and grip strength, but completely removed
associations between ALM/height2 and each of the nonhip
fracture outcomes (HRs 1.01 to 1.02). Furthermore, the HR for hip
fracture inverted to suggest a detrimental effect of increasing
lean mass on hip fracture risk after adjustment for aBMD (HR
1.12; 95% CI, 1.01 to 1.23). Figure 1 depicts the effect of the
different adjustments, using the participants in whomFRAX data
were available.
Interactions with age and follow-up time
In models incorporating age or follow-up time as interaction
terms, there was no evidence that either variable inﬂuenced the
predictive value of any of the four exposures. Thus, for chair
stand time, the HR for any fracture was 1.08 (95% CI, 0.98 to 1.19)
at age 70 years and 1.15 (95% CI, 1.08 to 1.21) at 80 years, p
interaction¼ 0.12. The HR for any fracture with walking speed
was 0.88 (95% CI, 0.81 to 0.95) at 1 year after baseline and 0.94
(95% CI, 0.87 to 1.01) at 10 years after baseline, p interaction
¼ 0.28. All other interaction terms were p> 0.30.
Discussion
We have demonstrated, in this large population cohort of older
men, that physical performance (chair stand time, walking
speed, grip strength) and ALM predict incident fracture risk
independently of FRAX probability and history of prior falls.
Though chair stand time, walking speed, and grip strength also
predicted fracture risk independently of femoral neck aBMD
(albeit with a slightly attenuated effect size), the inclusion of
aBMD directly, or as part of FRAX, markedly attenuated
associations between ALM and incident fracture.
There are several studies across a range of cohorts that
demonstrate the predictive value of measures such as chair
stand time, walking speed, and grip strength for fractures. The
associations we have observed are consistent with those for
physical performance, fractures, and falls derived using a
different analytic methodology in the US MrOS cohort.(3–5,28,29)
In the present analysis, however, we have, across the threeMrOS
cohorts, extended such ﬁndings by demonstrating that the
associations between these risk factors and incident fracture are
independent of key clinical factors such as prior falls, BMI, and
FRAX probability. Associations between appendicular lean mass
and fracture reported in previous studies are mixed, with no
association between ALM/height2 and hip fracture found in the
US MrOS cohort(30) or in women in the Framingham study,(31)
whereas a study of Swiss retirees found that low leanmass was a
risk factor for clinical fractures.(32)
The attenuation (and indeed inversion for hip fracture) of the
relationships between ALM and incident fracture by the
inclusion of femoral neck aBMD are intriguing. A similar ﬁnding
was observed in the Women’s Health Initiative(33) and in the
Health ABC study,(34) with the authors of the latter study
suggesting that excess lean in excess of bone mass might be a
profracture state. However, this would seem to be at odds with
the general adaptation of bone to muscle,(35) and excess lean
mass or power over bone strength seems unlikely in older men
(compared with younger athletes, for example). In contrast, in
the Swiss GERICO (Geneva Retired Workers cohort) study,
adjustment of low lean mass for aBMD did not substantially
attenuate associations with incident fracture.(32) Importantly,
both the measure of lean mass and aBMD are derived from the
Table 3. Associations Between Exposures and Risk of Incident Fracture
Exposure (SD) Adjustment Any fx Ost fx MOF fx Hip fx
Time 5 chair stands Age, FU time 1.15 (1.10, 1.21) 1.19 (1.13, 1.25) 1.26 (1.19, 1.34) 1.36 (1.24, 1.49)
þ prior falls 1.15 (1.09, 1.20) 1.18 (1.12, 1.24) 1.24 (1.17, 1.31) 1.34 (1.23, 1.47)
orþ FRAX wo aBMD 1.13 (1.07, 1.20) 1.17 (1.10, 1.24) 1.26 (1.17, 1.35) 1.31 (1.17, 1.46)
orþ FRAX with aBMD 1.12 (1.06, 1.19) 1.16 (1.09, 1.23) 1.24 (1.15, 1.34) 1.29 (1.15, 1.44)
orþ FN aBMD 1.16 (1.11, 1.21) 1.19 (1.13, 1.25) 1.26 (1.19, 1.34) 1.35 (1.23, 1.48)
Walking speed Age, FU time 0.91 (0.86, 0.95) 0.88 (0.83, 0.93) 0.85 (0.79, 0.90) 0.70 (0.64, 0.77)
þ prior falls 0.91 (0.87, 0.95) 0.88 (0.83, 0.93) 0.85 (0.80, 0.90) 0.71 (0.65, 0.79)
orþ FRAX wo aBMD 0.88 (0.83, 0.93) 0.85 (0.80, 0.91) 0.82 (0.76, 0.88) 0.70 (0.62, 0.78)
orþ FRAX with aBMD 0.89 (0.84, 0.95) 0.85 (0.80, 0.91) 0.83 (0.77, 0.90) 0.71 (0.63, 0.80)
orþ FN aBMD 0.90 (0.86, 0.94) 0.87 (0.83, 0.92) 0.84 (0.79, 0.89) 0.71 (0.65, 0.78)
Grip strength Age, FU time 0.83 (0.79, 0.86) 0.79 (0.75, 0.83) 0.77 (0.72, 0.82) 0.72 (0.65, 0.79)
þ prior falls 0.83 (0.79, 0.88) 0.79 (0.75, 0.84) 0.78 (0.73, 0.83) 0.72 (0.65, 0.80)
orþ FRAX wo aBMD 0.84 (0.79, 0.89) 0.81 (0.76, 0.87) 0.79 (0.73, 0.85) 0.74 (0.66, 0.84)
orþ FRAX with aBMD 0.85 (0.80, 0.90) 0.83 (0.77, 0.89) 0.81 (0.75, 0.87) 0.76 (0.68, 0.86)
orþ FN aBMD 0.86 (0.82, 0.90) 0.83 (0.78, 0.88) 0.82 (0.77, 0.87) 0.79 (0.71, 0.87)
ALM/Height2 Age, FU time 0.89 (0.84, 0.93) 0.88 (0.83, 0.93) 0.85 (0.80, 0.90) 0.86 (0.78, 0.95)
þ prior falls 0.88 (0.84, 0.93) 0.88 (0.83, 0.93) 0.86 (0.80, 0.91) 0.86 (0.78, 0.95)
orþ FRAX wo aBMD 0.93 (0.88, 0.99) 0.93 (0.87, 0.99) 0.89 (0.82, 0.96) 0.91 (0.81, 1.02)
orþ FRAX with aBMD 0.95 (0.90, 1.01) 0.95 (0.89, 1.01) 0.92 (0.85, 0.99) 0.95 (0.85, 1.07)
orþ FN aBMD 1.01 (0.96, 1.06) 1.02 (0.96, 1.08) 1.02 (0.96, 1.10) 1.12 (1.01, 1.23)
Data are hazard ratios (HRs) for fracture (fx) per 1 SD change in predictor (HR/SD), adjusted for age, follow-up time, and additional adjustment for either
prior falls, FRAXMOFwithout femoral neck aBMD, FRAXMOFwith femoral neck aBMD, femoral neck aBMD. Statistically signiﬁcant associations (p< 0.05)
are in bold.
fx¼ fracture; Ost¼ osteoporotic; MOF¼major osteoporotic fracture; FU¼ follow-up; FRAX¼ fracture risk assessment tool; FN¼ femoral neck.
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same instrument, namely DXA, and were moderately correlated
with a Pearson correlation coefﬁcient ranging from 0.29 (USA) to
0.43 (Hong Kong). It is well established that soft tissue can
inﬂuence the measurement of aBMD, potentially through a
magniﬁcation artifact associated with a thicker body where BMI
is higher, and through altered edge detection.(36) This
phenomenon has been particularly discussed in terms of
adipose tissue; the effect of muscle mass, which is not
speciﬁcally measured by DXA (it is derived as the tissue that is
not fat or bone), has been much less thoroughly considered.
Interestingly, the effect was very similar when ALM rather than
ALM/height2was used (data not shown), suggesting that it is not
solely a result of size adjustment, although both ALM and ALM/
height2 are strongly related to body size. The marked
attenuation of associations using ALM/BMI is likely to be a
consequence of ALM being a component of body weight
(together with fat mass and bone mass), with BMI calculated as
weight divided by height squared. Importantly, aBMD is
calculated from equations incorporating soft tissue mass(36);
thus the possibility of measurement artifact must be considered.
Assessment of muscle using an alternative modality, such as
pQCT, might offer a potential route to clariﬁcation of this issue.
We studied three well-characterized cohorts drawn from
general populations with standardized assessments and pro-
spective recording of fractures. However, there are some
limitations that should be considered in the interpretation of
our ﬁndings.(18) First, the population studied was male, and of a
narrow age range (64 to 99 years), thus limiting the
generalizability of our ﬁndings. Second, the deﬁnition of
glucocorticoid use differed from those usually speciﬁed for
incorporation into FRAX. Third, there was no information on
causes of secondary osteoporosis (other than rheumatoid
arthritis and glucocorticoids), and this variable was therefore
set to null. The effect of these considerations on our ﬁndings is
uncertain, but may have led to an underestimation of risk by
FRAX. Fourth, we were limited to DXAmeasures of lean mass, so
that both lean and bonemeasures were obtained from the same
scanner—DXA only approximates muscle mass. Finally, we did
not speciﬁcally investigate any additional effect of multiple falls,
and did not have information on the severity of a past fall, or
whether a past fall was associated with injury, hence limiting our
ability to identify events potentially most likely to be associated
with a fracture outcome.
Although these results clearly demonstrate that measures
such as chair stand time, walking speed, grip strength, and
ALM offer risk information over and above FRAX with aBMD,
how these might be incorporated into clinical assessment will
require further investigation. An important consideration is
whether the speciﬁc component of risk informed by each of
these measures is amendable to intervention. Thus far, there
are no medications licensed for the improvement of any of
these measures, and there is no evidence for the efﬁcacy of
currently used antiosteoporosis therapies among individuals
selected on the basis of such risk factors. Indeed, there is scant
evidence that nonpharmacological interventions, for example,
alterations to diet and/or physical activity to improve physical
performance, actually reduce fracture risk.(37,38) For the
moment then, these measures are most likely to be of
adjunctive use in clinical decision making, perhaps to guide
interventions for those close to intervention thresholds
derived from FRAX and aBMD assessment, but also as the
basis for directed nonpharmacological therapeutic approaches
focused, for example, on reducing the risk of falls.(37,38) They
may also be particularly relevant in older frail patients, who are
often assessed in the context of multidisciplinary falls/ frailty
clinics.
Fig. 1. Associations between exposures and risk of incident fracture. Data are hazard ratio for fracture per 1 SD change in predictor (HR/SD), adjusted for
age, follow-up time, and as speciﬁed (in a subset of N¼ 7531 participants: n¼ 1661 Hong Kong; n¼ 1732 Sweden; n¼ 4138 United States).
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In conclusion, we have demonstrated that physical performance
(chair stand time, walking speed, grip strength) and ALM are
predictive of incident fractures, independently of prior falls and
FRAX probability. The observation that inclusion of aBMD in the
models markedly attenuated the predictive value of ALM requires
further investigation to differentiate a true effect from artifact
caused by DXA technology. Although our ﬁndings support the
consideration of thesemeasures in fracture risk assessment, further
prospective studies in cohorts with wider age ranges, other
ethnicities, and most importantly women, are now warranted to
replicate and extend these ﬁndings, ideally to establish the
potential for their inclusion as a modiﬁer of FRAX probability.
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